Rigel Pharmaceuticals, Inc. (RIGL)
RIGLNASDAQ-GSBiotechnology: Pharmaceutical Preparations
$43.68
+1.63 (+3.88%) today
Regular session, Nov 10, 3:26 PM ET
- Market cap
- $822.49m
- P/E
- 14.1
- EPS, last 4 quarters
- $3.11
- Dividend yield
- –
- Day range
- $41.91 to $43.97
- 52-week range
- $24.95 to $52.61
- Average volume
- 237.4k
- Previous close
- $42.05
Analysts
3 coveringHold1 buy, 2 hold, 0 sell
Targets a year out average $66.75, +52.8% from here
Earnings
next estimate $0.8900Next report
Dec 2025
-14.3%
Mar 2026
-40.5%
Jun 2026
-3.3%
Sep 2026
-25.3%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $69.80m | $58.82m | $78.70m | $80.89m |
| Gross profit | $63.85m | $54.21m | $70.18m | $70.11m |
| Operating income | $23.17m | $11.88m | $23.57m | $17.11m |
| Net income | $268.06m | $8.65m | $17.29m | $13.19m |
Last four quarters: revenue $288.21m, margin 106.6%, free cash flow –
News
8 latest- Rigel Pharmaceuticals Q3 Earnings Call HighlightsMarketBeat · 4 days ago
- Rigel (RIGL) Q3 2026 Earnings Call TranscriptThe Motley Fool · 5 days ago
- Rigel Pharmaceuticals (RIGL) Misses Q3 Earnings EstimatesZacks · 5 days ago
- United Therapeutics (UTHR) Q3 Earnings Miss EstimatesZacks · 6 days ago
- Reasons Why Investors Should Consider Betting on Arvinas StockZacks · Oct 13, 2026
- Rigel (RIGL) Q2 2026 Earnings Call TranscriptThe Motley Fool · Aug 11, 2026
- Rigel Pharmaceuticals Q2 Earnings Call HighlightsMarketBeat · Aug 4, 2026
- Rigel Pharmaceuticals (RIGL) Q2 Earnings Miss EstimatesZacks · Aug 4, 2026
The company
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- rigel.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.